-

11:12:10 PM

ISO Stock News

ISO - IsoPlexis Corp

03/21/23 8:02 AM

Nasdaq : BLI, ISO, CELL

acquisition

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

Berkeley Lights, Inc., a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation, a company empowering labs to leverage the cells and proteome changing the course of human health. The successful combination of Berkeley Lights and IsoPlexis lays the foundation for a financially...

RHEA-AI

very positive

01/12/23 4:05 PM

Nasdaq : ISO

low float

IsoPlexis Reports Preliminary Full Year 2022 Revenue

IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced its preliminary unaudited revenue for the full year ended December 31, 2022. Total revenue for

RHEA-AI

neutral

12/21/22 4:49 PM

Nasdaq : ISO

acquisitionlow float

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights Expected as a Standalone Entity Companies to

RHEA-AI

very positive

12/21/22 4:15 PM

Nasdaq : BLI, ISO

acquisition

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell BiologySignificant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights Expected as a Standalone EntityCompanies to

RHEA-AI

very positive

11/10/22 7:00 AM

Nasdaq : ISO

earningslow float

IsoPlexis Reports Third Quarter 2022 Financial Results

IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today reported financial results for the quarter ended September 30, 2022. Recent Highlights Revenue of $4.5

RHEA-AI

neutral

11/09/22 7:00 AM

Nasdaq : ISO

conferenceslow float

IsoPlexis to Participate in Upcoming Investor Conferences

IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will be participating in the following investor conferences. Canaccord Genuity MedTech,

RHEA-AI

neutral

10/19/22 7:00 AM

Nasdaq : ISO

conferencesearningslow float

IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will report financial results for the third quarter 2022 before market open on Thursday,

RHEA-AI

neutral

09/13/22 7:00 AM

Nasdaq : ISO

low float

IsoPlexis Announces First APAC Publication, Illustrating Early Impact of Codeplex Platform

IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced the publication of initial data off its CodePlex platform in the journal

RHEA-AI

neutral

09/06/22 7:00 AM

Nasdaq : ISO

partnershipcovid-19low float

IsoPlexis Partners with MediMergent and The Center for Cancer and Blood Disorders in Study of AZD7442 for Prevention of COVID-19 Infection in Immuno-Compromised Cancer Patients

IsoPlexis (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a

RHEA-AI

positive

08/31/22 7:00 AM

Nasdaq : ISO

conferenceslow float

IsoPlexis to Participate in the Morgan Stanley Global Healthcare Conference

IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will be participating in the upcoming Morgan Stanley Global Healthcare

RHEA-AI

neutral

ISO Data

IndustryTesting Laboratories
Websiteisoplexis.com
Security nameIsoPlexis Corp
SectorProfessional, Scientific, and Technical Services

About IsoPlexis Corp

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States and Europe. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations without the need for highly specialized informatics professionals, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.